Showing results (811-820 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|January 10, 2021
Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trialJordana B Cohen, Thomas C Hanff, Preethi William, et al.
The Lancet. Respiratory Medicine|January 11, 2021
Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort studyBrenda T Pun, Rafael Badenes, Gabriel Heras La Calle, et al.
The Lancet. Respiratory Medicine|May 31, 2021
Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohortGiorgia Radicioni, Agathe Ceppe, Amina A Ford, et al.
The Lancet. Respiratory Medicine|May 30, 2021
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trialJean-Claude Tardif, Nadia Bouabdallaoui, Philippe L L'Allier, et al.
The Lancet. Respiratory Medicine|June 14, 2017
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trialFelix Ratjen, Christopher Hug, Gautham Marigowda, et al.
The Lancet. Respiratory Medicine|October 7, 2021
Changes in lung function in European adults born between 1884 and 1996 and implications for the diagnosis of lung disease: a cross-sectional analysis of ten population-based studiesJames P Allinson, Shoaib Afzal, Yunus Çolak, et al.
The Lancet. Respiratory Medicine|February 21, 2022
Association between very to moderate preterm births, lung function deficits, and COPD at age 53 years: analysis of a prospective cohort studyDinh S Bui, Jennifer L Perret, E Haydn Walters, et al.
The Lancet. Respiratory Medicine|October 2, 2021
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort studyUtkarsh Agrawal, Srinivasa Vittal Katikireddi, Colin McCowan, et al.
The Lancet. Respiratory Medicine|July 11, 2022
Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
The Lancet. Respiratory Medicine|March 26, 2022
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventionsKeertan Dheda, Tahlia Perumal, Harry Moultrie, et al.
Pageof 104